Invivyd Inc
News Catalyst · detected 2026-06-01 13:36 · Healthcare · Biotechnology
Risk : Reward
1 : 10.0
Likelihood
9%
Historical win rate of this setup typeRisk multiplier
1.00×
Normal sizingScore
85
Time to reward
1 week
Estimated holding period for reward realizationExpected R
-0.56R
From 22 closed setups · bucket: news:39|mag:unknownTrade levels
Entry1.17
Stop1.06
Risk / share0.11
Target 1 (3R)1.50
Target 2 (5R)1.72
Target 3 (10R)2.27
Rationale
News id
13234
Category
Phase3Positive
Headline
Invivyd Announces Completion of Enrollment in Upsized DECLARATION Clinical Trial, a Phase 3 Pivotal Study of VYD2311, an Investigational Antibody to Prevent COVID
Published utc
2026-06-01T07:01:00
Risk multiplier
1
Stop template
PreMarketLow
Sector
Healthcare
Industry
Biotechnology
Market cap
344.69M
Magnitude usd
—
Magnitude anchor
—
Magnitude percent of mcap
—
Magnitude bonus
0
Gann confluence
In zone
In zone
Current zone score 17 · reaction rate 100% · 300 clusters tracked · bars used 1213
| Date | Price | Score | Price levels | Time levels |
|---|---|---|---|---|
| 2021-12-02 | 1.11 | 15.27 | 13 | 36 |
| 2021-12-02 | 1.36 | 9.65 | 9 | 36 |
| 2021-12-02 | 0.91 | 6.54 | 4 | 36 |
| 2021-12-02 | 0.79 | 6.41 | 4 | 36 |
| 2021-12-02 | 1.50 | 6.29 | 7 | 36 |
| 2021-12-02 | 0.66 | 5.94 | 7 | 36 |
| 2021-12-02 | 0.51 | 4.81 | 4 | 36 |
| 2021-12-02 | 1.21 | 4.56 | 3 | 36 |
| 2021-12-02 | 1.64 | 3.75 | 4 | 36 |
| 2021-12-02 | 1.80 | 3.11 | 3 | 36 |